Chemoinformaics analysis of SOPHORACOUMESTAN-A
| Molecular Weight | 334.327 | nRot | 0 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 26 |
| Exact Molecular Weight | 334.084 | nRing | 5 |
| Solubility: LogS | -4.85 | nHRing | 3 |
| Solubility: LogP | 4.916 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 17 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 20 |
| nHA | 5 | APOL | 46.7451 |
| nHD | 1 | BPOL | 20.1209 |
| QED | 0.476 |
| Synth | 2.972 |
| Natural Product Likeliness | 2.093 |
| NR-PPAR-gamma | 0.951 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.587 |
| Pgp-sub | 0.01 |
| HIA | 0.015 |
| CACO-2 | -4.865 |
| MDCK | 0.000022 |
| BBB | 0.014 |
| PPB | 0.935942 |
| VDSS | 0.539 |
| FU | 0.0879963 |
| CYP1A2-inh | 0.975 |
| CYP1A2-sub | 0.644 |
| CYP2c19-inh | 0.907 |
| CYP2c19-sub | 0.085 |
| CYP2c9-inh | 0.836 |
| CYP2c9-sub | 0.928 |
| CYP2d6-inh | 0.825 |
| CYP2d6-sub | 0.837 |
| CYP3a4-inh | 0.729 |
| CYP3a4-sub | 0.135 |
| CL | 3.936 |
| T12 | 0.233 |
| hERG | 0.016 |
| Ames | 0.068 |
| ROA | 0.267 |
| SkinSen | 0.698 |
| Carcinogencity | 0.808 |
| EI | 0.227 |
| Respiratory | 0.664 |
| NR-Aromatase | 0.905 |
| Antiviral | Yes |
| Prediction | 0.650349 |